158 related articles for article (PubMed ID: 16603514)
1. Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency.
Ford PW; Bryan BA; Dyson OF; Weidner DA; Chintalgattu V; Akula SM
J Gen Virol; 2006 May; 87(Pt 5):1139-1144. PubMed ID: 16603514
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
[TBL] [Abstract][Full Text] [Related]
3. Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1.
Qin D; Feng N; Fan W; Ma X; Yan Q; Lv Z; Zeng Y; Zhu J; Lu C
BMC Microbiol; 2011 Oct; 11():240. PubMed ID: 22032493
[TBL] [Abstract][Full Text] [Related]
4. An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus.
Cohen A; Brodie C; Sarid R
J Gen Virol; 2006 Apr; 87(Pt 4):795-802. PubMed ID: 16528027
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-κB signaling pathways.
Zhu X; Zhou F; Qin D; Zeng Y; Lv Z; Yao S; Lu C
J Mol Biol; 2011 Jul; 410(5):1035-51. PubMed ID: 21763505
[TBL] [Abstract][Full Text] [Related]
6. Identifying cellular genes crucial for the reactivation of Kaposi's sarcoma-associated herpesvirus latency.
Bryan BA; Dyson OF; Akula SM
J Gen Virol; 2006 Mar; 87(Pt 3):519-529. PubMed ID: 16476973
[TBL] [Abstract][Full Text] [Related]
7. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.
Lagunoff M; Bechtel J; Venetsanakos E; Roy AM; Abbey N; Herndier B; McMahon M; Ganem D
J Virol; 2002 Mar; 76(5):2440-8. PubMed ID: 11836422
[TBL] [Abstract][Full Text] [Related]
8. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency.
Ye F; Zhou F; Bedolla RG; Jones T; Lei X; Kang T; Guadalupe M; Gao SJ
PLoS Pathog; 2011 May; 7(5):e1002054. PubMed ID: 21625536
[TBL] [Abstract][Full Text] [Related]
10. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.
Papp B; Motlagh N; Smindak RJ; Jin Jang S; Sharma A; Alonso JD; Toth Z
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541837
[TBL] [Abstract][Full Text] [Related]
12. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
[TBL] [Abstract][Full Text] [Related]
13. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Kaposi's sarcoma-associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection.
Pan H; Xie J; Ye F; Gao SJ
J Virol; 2006 Jun; 80(11):5371-82. PubMed ID: 16699017
[TBL] [Abstract][Full Text] [Related]
15. Acetylation changes at lysine 5 of histone H4 associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus.
Hwang LR; Cha S; Jong JE; Jang JH; Seo T
Acta Virol; 2014; 58(3):282-6. PubMed ID: 25283865
[TBL] [Abstract][Full Text] [Related]
16. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
17. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
18. Evidence of inability of human cytomegalovirus to reactivate Kaposi's sarcoma-associated herpesvirus from latency in body cavity-based lymphocytes.
Cheng B; Martínez FP; Katano H; Tang Q
J Clin Virol; 2009 Nov; 46(3):244-8. PubMed ID: 19726225
[TBL] [Abstract][Full Text] [Related]
19. Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.
Chiou CJ; Poole LJ; Kim PS; Ciufo DM; Cannon JS; ap Rhys CM; Alcendor DJ; Zong JC; Ambinder RF; Hayward GS
J Virol; 2002 Apr; 76(7):3421-39. PubMed ID: 11884567
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]